hsCRP tells you something about whole-body inflammation and very little about whether one particular joint is inflamed. In an analysis of 792 participants in the NIH-funded MOST knee osteoarthritis cohort, inflammation was present on MRI in 28% of knees, and hsCRP showed no association with the presence of that inflammation or with its average score — the ROC curve indicated poor ability to identify which knees were inflamed [1]. The authors’ conclusion was direct: hsCRP levels do not reliably identify knees with inflammation [1].
That is worth knowing before you draw conclusions from a lab result. A normal hsCRP does not clear a joint, and a raised one does not convict it.
What hsCRP actually measures
High-sensitivity C-reactive protein is an assay sensitive enough to detect low-grade systemic inflammatory activity, well below the range used to flag acute infection. It reflects signaling across the whole body.
A joint, by contrast, has its own local environment: synovium, subchondral bone, the mechanical loading history of that specific knee or hip. Those processes can run without moving a systemic marker, which is the mismatch the MOST analysis measured directly.
The MOST analysis in detail
Participants had baseline knee MRIs and hsCRP assays. Inflammation was scored using the Whole-Organ MRI Score, with presence defined as Hoffa’s synovitis or effusion-synovitis scoring 2 or higher in at least one of three locations, and analyses were adjusted for age, sex, and body mass index [1].
Among the 792 participants, mean age 62 and 52% female, mean hsCRP was 2.98 mg/dL and 41% had hsCRP at or above 2 mg/dL. Neither the continuous nor the dichotomized measure associated with MRI-defined inflammation, and cubic spline regression found no non-linear relationship either [1].
Where hsCRP does carry population-level signal
At the population level the picture is different. An analysis of US adults in the National Health and Nutrition Examination Survey for 2015 to 2018 reported an association between higher serum hsCRP levels and osteoarthritis [2].
A population association and an individual diagnostic test are not the same thing, and this is the single most common misreading of an inflammatory marker. A signal that holds across thousands of people can be useless for deciding what is happening in your left knee.
How we use biomarkers without over-reading them
We use systemic markers to describe the terrain a joint is trying to heal in — metabolic and inflammatory load, and what that implies about healing capacity — rather than as a proxy for what is happening inside the joint. That framing is set out in the metabolic bottleneck.
Serial values are more informative than a single one, and any value needs its context: recent illness, injury, or another inflammatory trigger will move it. Where orthobiologic options fit once that picture is assembled is described in our orthobiologics overview.
Three questions worth asking about your own result
Ask what the value was ordered to answer, whether anything was happening in your body at the time that would move it, and what the plan would target differently depending on the answer. A number that changes nothing about the plan is a number that did not need drawing.
Bring your imaging and your labs to a physician
Regen.MD begins with a physician-led Clinical Evaluation — a review of your history, imaging, and metabolic data, and a written terrain roadmap. Evaluation is contingent upon review of your data.
Questions? Call (314) 295-3000 or text (314) 886-5902.
Frequently asked questions
Can hsCRP tell me whether my knee osteoarthritis is the inflammatory kind?
No. In 792 participants in the MOST knee osteoarthritis cohort, hsCRP showed no association with MRI-defined inflammation whether measured continuously or split at 2 mg/dL, and its ability to identify inflamed knees on ROC analysis was poor. The determination has to come from the joint itself alongside your examination, which is how we sequence it in our evaluation and treatment approach.
Then why is hsCRP linked to osteoarthritis in the news?
Because population studies and individual diagnosis are different questions. An analysis of US adults in NHANES 2015 to 2018 did report an association between higher hsCRP and osteoarthritis, which describes a pattern across a national sample rather than a test that works on one person. How we place systemic markers inside a fuller picture is set out in the metabolic audit.
Should a high hsCRP change whether I have an orthobiologic injection?
Not on its own. A raised systemic marker may say something about metabolic and inflammatory load and therefore about healing capacity, but it does not localize a problem to a joint or select a procedure. Those decisions come from examination, imaging, and symptom pattern together, which is how we approach the joints described on our joint dysfunction page.
What else gets checked alongside hsCRP?
That depends entirely on the question being asked, and we would rather order fewer tests that change a decision than a broad panel that does not. Nothing in the studies cited here establishes a standard companion panel for degenerative joint disease, and we will not imply one exists. Evidence summaries on how we read metabolic and inflammatory data are collected in the library.
Sources
- George N, Liew JW, Wang N, et al. Does hsCRP provide insights into an inflammatory phenotype of knee osteoarthritis? Osteoarthritis and Cartilage. 2026;34(5). https://pmc.ncbi.nlm.nih.gov/articles/PMC12431637/ (referenced for: 792 MOST participants, mean age 62, 52% female; mean hsCRP 2.98 mg/dL with 41% at or above 2 mg/dL; inflammation present in 28% of knees; WORMS scoring definition; no association between hsCRP and inflammation presence or average score, including dichotomized and cubic spline analyses; poor ROC predictive ability; adjustment for age, sex, and BMI).
- Gao T, Chen ZY, Li T, et al. Association between serum high-sensitivity C-reactive protein levels and osteoarthritis in adults from NHANES 2015 to 2018. Scientific Reports. 2025;15. https://pmc.ncbi.nlm.nih.gov/articles/PMC11829964/ (referenced for: the population-level association between higher serum hsCRP and osteoarthritis among US adults in NHANES 2015–2018).